Clinical Trial Update: Secretome TGF Beta 3 [NA]

View source ↗

Summary

A clinical trial is planned to evaluate Secretome TGF Beta 3 for melasma, with status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Secretome TGF Beta 3 (Transforming Growth Factor Beta 3)

Snippet

Sponsor: Indonesia University | Conditions: Melasma | NA | Status: NOT_YET_RECRUITING